Hydrogen gas helps with post-cardiac arrest syndromeScientific Research
Feasibility and Safety of Hydrogen Gas Inhalation for Post-Cardiac Arrest Syndrome – First-in-Human Pilot Study –
Hydrogen (HI) inhalation improves brain and cardiac dysfunction in an animal model of post-cardiac arrest syndrome (PCAS). HI in human patients with PCAS has never been studied.
METHODS AND RESULTS
Between January 2014 and January 2015, 21 of 107 out-of-hospital cardiac arrest patients achieved spontaneous cardiac recovery. After excluding 16 patients with specific criteria, 5 patients underwent HI and target temperature management (TTM). No adverse events related to HF were observed, and 4 patients survived for 90 days with favorable neurological outcomes.
HI combined with TTM is a feasible treatment for PCAS patients. (Circ J 2016;80:1870-1873)
- 5. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452–2483.